U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling more than 100 points on Friday.

LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.

Biomea stock rises 9% after the FDA lifts clinical hold on two phase I/II studies evaluating the company's lead candidate, BMF-219, for diabetes.

Advanced techniques for trading penny stocks can significantly enhance profitability for experienced investors. One key strategy is to capitalize on technical analysis.

Advanced techniques for trading penny stocks can significantly enhance profitability for experienced investors. One key strategy is to capitalize on technical analysis.

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round breast implants in primary and revision breast augmentation. “Today's approval is transformative for breast aesthetics in.

Bill Bishop, publisher of the Sinocism China Newsletter, and Derek Scissors, Asia economist at the American Enterprise Institute, join CNBC's 'The Exchange' to discuss China's recent stimulus package, how long its rally can last, and more.

REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent small molecules to treat and improve the lives of patients with metabolic diseases and genetically defined cancers, today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on Biomea's ongoing Phase I/II clinical trials of the Company's investigational covalent menin inhibitor BMF-219 in type 2 and type 1 diabetes (COVALENT-111 and COVALENT-112), respectively.

LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.

BEIJING , Sept. 26, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S. listed EV charging service company in China, today announced a strategic partnership with IM Motors, an electric vehicle joint venture among Alibaba, SAIC Motor, and Zhangjiang Hi-Tech, focused on the design and manufacture of high-end intelligent electric vehicles.

LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.

ZURICH, SWITZERLAND / ACCESSWIRE / September 25, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that a reverse share split of the Company's issued and outstanding common shares, par value CHF 0.02 per share (the "Common Shares"), at a ratio of 1-for-40 is expected to be implemented at market open on September 27, 2024 (the "Reverse Split").

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.

LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market.

FORT MILL, S.C. , Sept. 5, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China, and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ: XFIN), a publicly traded special purpose acquisition company, today announced that Baird Medical Investment Holdings Limited's ("PubCo") registration statement on Form F-4 (the "Registration Statement") related to their previously announced proposed business combination (the "Business Combination") has been declared effective by the U.S. Securities and Exchange Commission (the "SEC").

The Dow Jones index closed lower by more than 50 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

OneConnect Financial Technology Co., Ltd. (NYSE:OCFT ) Q2 2024 Earnings Conference Call August 16, 2024 8:00 AM ET Company Participants Rick Chan - Head of IR Shen Chongfeng - Chairman & CEO Luo Yongtao - CFO Conference Call Participants Judy Zhang - Citigroup Operator Ladies and gentlemen, thank you for standing by and welcome to OneConnect Second Quarter 2024 Earnings Call.

BEIJING , Aug. 12, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NaaS) ("NaaS" or the "Company"), the first U.S. listed EV charging service company in China, today announced that Mr. Alex Wu, President, Chief Financial Officer and Director of the Company, resigned from the Company for personal reasons, effective August 9, 2024.

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.65 per share a year ago.

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 0.4% on Monday.

NLS Pharmaceutics (NASDAQ: NLSP ) stock is on the rise Monday after the clinical-stage biopharmaceutical company announced a merger agreement with Kadimastem. This agreement will see Kadimastem acquired by a wholly-owned subsidiary of NLS Pharmaceutics.

The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages of clinical development and focused on advancing Kadimastem's allogeneic cell therapy platform Each of Kadimastem and NLS Pharmaceutics has received commitments of support for the transaction from shareholders representing more than 40% of their respective outstanding shares ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / July 29, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical company.

NaaS Technology Inc. (NASDAQ:NAAS ) Q2 2024 Earnings Conference Call July 24, 2024 8:00 AM ET Company Participants John Wang - Director of Investor Relations Wang Yang - Chief Executive Officer Alex Wu - President and Chief Financial Officer Conference Call Participants Ting Song - Goldman Sachs James Zou - UBS Ethan Zhang - Nomura Zoe Feng - Tianfeng Securities Operator Ladies and gentlemen, thank you for standing by, and welcome to the NaaS Second Quarter and First Half 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2024, after the market closes on Tuesday, August 6, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (800) 715-9871 (U.S. and Can.

BEIJING , July 23, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S. listed EV charging service company in China, today announced that it will report its unaudited financial results for the second quarter and half year ended June 30, 2024 before the U.S. market opens on Wednesday, July 24, 2024. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern time on July 24, 2024 (8:00 PM Beijing/Hong Kong time on July 24, 2024).

IRVINE, Calif. , July 21, 2024 /PRNewswire/ -- ATIF Holdings Limited (NASDAQ: ATIF, the "Company" or "ATIF") announced that its subsidiary ATIF Business Management LLC has entered into a listing advisory services agreement with two U.S. based technology companies.

200 Sites Renewable 5-year NaaS Agreement Initial Drawdown of US$ 2. MUSD Received Resumption of NuRAN New Site Builds QUEBEC, QC / ACCESSWIRE / July 16, 2024 / NuRAN Wireless Inc. ("NuRAN" or the "Company") (CSE:NUR)(OTC PINK:NRRWF)(FSE:1RN), a leading supplier of mobile and broadband wireless infrastructure solutions, is pleased to announce an agreement for up to 200 sites with MTN Benin (JSE:MTN) for the deployment of rural 2G, 3G and 4G sites under the Network-as-a-Service ("NaaS") business model in Benin, West Africa.

ZURICH, SWITZERLAND / ACCESSWIRE / June 28, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 3,277,750 of its common shares at a purchase price of $0.24 per share in a registered direct offering.

ZURICH, SWITZERLAND / ACCESSWIRE / June 27, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, today announced preclinical results from multiple in vitro studies targeting alpha-synuclein (α-synuclein), specifically the A53T mutation, that demonstrate the compounds' potential to advance the treatment of Parkinson's Disease (PD).

ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a leading Swiss biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, announced today that it received notice from the Nasdaq Hearings Panel ("Panel") of The Nasdaq Stock Market ("Nasdaq") that it has granted the Company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Market, as discussed more fully below.

Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

BEIJING , June 7, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NaaS) ("NaaS" or the Company"), the first U.S. listed EV charging service company in China, today provides an update on the effective date of the change of the ratio of its American Depositary Shares (the "ADSs") to its Class A ordinary shares (the "ADS Ratio"). The ADS Ratio change was previously announced on May 30, 2024 and originally planned to become effective on or about June 10, 2024.

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences. Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Chief Financial Officer, will participate in the 2024 Jefferies Global Healthcare Conference being held June 5-6, 2024. Mr. Chacón.

OneConnect Financial Technology Co., Ltd. (NYSE:OCFT ) Q1 2024 Earnings Conference Call May 21, 2024 8:00 AM ET Company Participants Rick Chan - Head of IR Shen Chong Feng - Chairman & CEO Luo Yongtao - CFO Conference Call Participants Lydia Lin - Morgan Stanley Laura Lee - CGS International Alan Kuang - Citigroup Operator Ladies and gentlemen, thank you for standing by, and welcome to OneConnect's First Quarter 2024 Earnings Call.

IRVINE, Calif. , May 14, 2024 /PRNewswire/ -- Armlogi Holding Corp. ("Armlogi"), consulted by ATIF Holdings Limited (NASDAQ: ATIF, "ATIF") (NASDAQ: BTOC), having its initial public offering on the Nasdaq Exchange.

NaaS Technology Inc. (NASDAQ:NAAS ) Q1 2024 Earnings Conference Call May 10, 2024 8:00 AM ET Company Participants John Wang - Director, Investor Relations Cathy Wang Yang - Chief Executive Officer Vivian Wu Ye - Chief Strategy Officer Alex Wu - President and CFO Conference Call Participants Zoe Feng - TF Securities Ting Song - Goldman Sachs Ethan Zhang - Nomura Operator Ladies and gentlemen, thank you for standing by. And welcome to the NaaS First Quarter 2024 Earnings Conference Call.

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.48 per share a year ago.

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, noted the presentation today of an update on the Motiva US IDE Study. The update will include four-year patient follow-up data for primary augmentation subjects. The Medical Director of the Study, Dr. Caroline Glicksman, who is also an Investigator in the Study, will present the re.

IRVINE, Calif. , April 17, 2024 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a company coached by ATIF Holdings Limited (NASDAQ: ATIF, hereinafter referred to as "ATIF"), announces its fiscal year 2023 financial results following a $5.85 million initial public offering.

IRVINE, Calif. , April 2, 2024 /PRNewswire/ -- MASSIMO GROUP (NASDAQ: MAMO), hereinafter referred to as "MASSIMO", consulted by ATIF Holdings Limited (NASDAQ: ATIF, hereinafter referred to as "ATIF") made its initial public offering on the NASDAQ Exchange under the ticker symbol MAMO.

OneConnect Financial Technology Co., Ltd. (OCFT) Q4 2023 Earnings Call Transcript

Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close Upon closing, Baird Medical is expected to trade on Nasdaq under the ticker symbol "BDMD" FORT MILL, S.C. , March 12, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China and the United States, and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ: XFIN), a publicly traded special purpose acquisition company, today announced a strategic update to their previously announced business combination agreement.

We have picked China stocks H World Group (HTHT), DouYu International (DOYU), Kanzhun (BZ), JinkoSolar (JKS) and OneConnect Financial (OCFT) that hold promise in 2024.

Enanta Pharmaceuticals (ENTA), OneConnect Financial. (OCFT), KNOT Offshore (KNOP), Hippo Holdings (HIPO) and H World Group (HTHT) could surprise investors with big returns this Christmas.

Bethesda, MD, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Alset Inc. (NASDAQ:AEI) ("AEI" or the "Company"), a diversified holding company principally engaged through its subsidiaries in the development of smart and sustainable home communities and other property development, financial services, digital transformation technologies, biohealth activities and consumer products, is pleased to announce the signing of a binding term sheet to acquire 100% of New Energy Asia Pacific Inc. (“NEAPI”). NEAPI owns approximately 41.5% of New Energy Asia Pacific Limited, a Hong Kong company (“New Energy”). New Energy focuses on distributing all-electric versions of special-purpose and transportation vehicles, charging stations and batteries.

IRVINE, Calif., Nov. 21, 2023 /PRNewswire/ -- ATIF Holdings Limited (NASDAQ: ATIF, the "Company" or "ATIF") announced that its subsidiary ATIF Business Management LLC has entered into a listing advisory services agreement with a U.S. based electronic technology innovation products company for an amount of US $800,000.00.

IRVINE, Calif. , Oct. 20, 2023 /PRNewswire/ -- ATIF Business Management LLC, a subsidiary of ATIF Holdings Limited (NASDAQ: ATIF, the "Company" or "ATIF"), has successfully guided Northann Corp. (hereinafter referred to as Northann) to list on the New York Stock Exchange.

NEW YORK , Oct. 17, 2023 /PRNewswire/ -- ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that the Special Meeting originally scheduled for October 18, 2023 (the "Special Meeting") is being adjourned to October 20, 2023. At the Special Meeting, the Company's stockholders will be asked: to consider and vote upon a proposal to amend the Company's amended and restated certificate of incorporation (the "Charter") pursuant to a second amendment to the Charter (the "Extension Amendment") to extend the date by which the Company must effectuate an initial business combination from October 25, 2023 (the "Termination Date") to April 25, 2024, comprised of an initial three-month extension and three subsequent one-month extensions, for a total of six months after the Termination Date (assuming the Company's initial business combination has not occurred); and to consider and vote upon a proposal to adjourn the Special Meeting to a later date or dates, if necessary, to (i) permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are not sufficient votes to approve one or more proposals presented to stockholders for vote or (ii) if stockholders have elected to redeem an amount of shares in connection with the Extension Amendment such that the Company would not adhere to the continued listing requirements of The Nasdaq Global Market ("Nasdaq") (the "Adjournment Proposal").

IRVINE, Calif. , Oct. 17, 2023 /PRNewswire/ -- Global Mofy Metaverse Limited, has successfully listed on NASDAQ, which is the first Chinese company to be successfully listed on Nasdaq after the implementation of the China Securities Regulatory Commission's new rules for overseas listing filing.

OneConnect Financial Technology Co., Ltd. (NYSE:OCFT ) Q2 2023 Earnings Conference Call August 16, 2023 8:00 AM ET Company Participants Rick Chan - Head of Investor Relations Shen Chong Feng - Chairman and Chief Executive Officer Luo Yongtao - Chief Financial Officer Jessie Shen - Head of Strategy, Corporate Planning and Product Management Conference Call Participants Timothy Zhao - Goldman Sachs Lydia Lin - Morgan Stanley Laura Lee - CGS-CIMB Operator Ladies and gentlemen, thank you for standing by, and welcome to OneConnect Second Quarter 2023 Earnings Call.

Gaining from the rising importance of technology services, HIVE, OCFT and TT can be considered by investors for their portfolios.

Alset (NASDAQ: AEI ) stock is taking a beating on Monday after the company announced a proposed public stock offering. The public offering was initially announced on Friday and has since been priced.

Small-cap stocks usually suffer more than mid- and large-cap stocks when the market as a whole is struggling, and when the market is rallying, they could offer higher returns as well.

HUNT VALLEY, Md.

Which penny stocks are you watching right now? The post Buying Penny Stocks This Week?

IonQ, a quantum computing specialist, has been awarded a $54.5 million, four-year contract from the U.S. Air Force Research Lab to develop quantum networking and interoperable systems. While IonQ's top line is growing, the company has a history of significant losses and a highly speculative valuation.

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling more than 100 points on Friday.

The U.S. Air Force Research Lab just awarded IonQ a $54.5 million, four-year quantum computing contract. IonQ is on pace to double its annual bookings for the third year in a row.

Advanced techniques for trading penny stocks can significantly enhance profitability for experienced investors. One key strategy is to capitalize on technical analysis.

COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), a leader in the quantum computing industry, today announced that it has signed a $54.5 million contract with the United States Air Force Research Lab (AFRL). With a quarter remaining in the fiscal year, IonQ has announced $72.8 million in bookings year-to-date and reiterated its confidence in meeting or exceeding its bookings guidance of $75-95 million for the year. Governments, businesses, and academia are investing in quantum computing to.